Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4+ T cells in primary sclerosing cholangitis

[1]  A. Franke,et al.  Monocytes as Potential Mediators of Pathogen-Induced T-Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC). , 2020, Hepatology.

[2]  R. Bowden,et al.  Single-cell atlas of colonic CD8+ T cells in ulcerative colitis , 2020, Nature Medicine.

[3]  Lei Liu,et al.  Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human , 2020, Cell Discovery.

[4]  M. Looso,et al.  Beyond accessibility: ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation , 2019, bioRxiv.

[5]  P. Sims,et al.  Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease , 2019, Nature Communications.

[6]  C. Ponting,et al.  Resolving the fibrotic niche of human liver cirrhosis at single cell level , 2019, Nature.

[7]  W. Lieb,et al.  Alterations of the bile microbiome in primary sclerosing cholangitis , 2019, Gut.

[8]  Dominic Grün,et al.  A Human Liver Cell Atlas reveals Heterogeneity and Epithelial Progenitors , 2019, Nature.

[9]  M. Altfeld,et al.  CCL21‐expression and accumulation of CCR7+ NK cells in livers of patients with primary sclerosing cholangitis , 2019, European journal of immunology.

[10]  D. Pe’er,et al.  Characterization of cell fate probabilities in single-cell data with Palantir , 2019, Nature Biotechnology.

[11]  M. Hattori,et al.  Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis , 2019, Nature Microbiology.

[12]  J. Borghans,et al.  The full spectrum of human naive T cells , 2018, Nature Reviews Immunology.

[13]  D. Farber,et al.  Human T Cell Development, Localization, and Function throughout Life. , 2018, Immunity.

[14]  T. Karlsen,et al.  Primary sclerosing cholangitis - a comprehensive review. , 2017, Journal of hepatology.

[15]  Yufeng Shen,et al.  Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites. , 2017, Cell reports.

[16]  Russell B. Fletcher,et al.  Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics , 2017, bioRxiv.

[17]  Mariza de Andrade,et al.  Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease , 2016, Nature Genetics.

[18]  Ho-Ryun Chung,et al.  Epigenomic Profiling of Human CD4+ T Cells Supports a Linear Differentiation Model and Highlights Molecular Regulators of Memory Development. , 2016, Immunity.

[19]  H. Tilg,et al.  Gut microbiome and liver diseases , 2016, Gut.

[20]  W. Lieb,et al.  Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis , 2016, Gut.

[21]  T. Karlsen,et al.  The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls , 2016, Gut.

[22]  H. Hermanns,et al.  Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver , 2016, The Journal of Immunology.

[23]  J. Schenkel,et al.  Tissue-resident memory T cells. , 2014, Immunity.

[24]  K. Rajewsky,et al.  STAT3 Activation in Th17 and Th22 Cells Controls IL-22–Mediated Epithelial Host Defense during Infectious Colitis , 2014, The Journal of Immunology.

[25]  G. Reynolds,et al.  Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis. , 2014, Gastroenterology.

[26]  F. Sallusto,et al.  The who's who of T‐cell differentiation: Human memory T‐cell subsets , 2013, European journal of immunology.

[27]  M. Neurath,et al.  Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis , 2013, Hepatology.

[28]  S. Ziegler,et al.  Hepatitis C virus promotes t‐helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes , 2013, Hepatology.

[29]  C. Mullighan,et al.  The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy. , 2012, Immunity.

[30]  D. Kavanagh,et al.  CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver , 2012, Journal of hepatology.

[31]  C. Ponsioen,et al.  Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. , 2012, Journal of hepatology.

[32]  P. Klenerman,et al.  Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. , 2012, Blood.

[33]  Cory Y. McLean,et al.  GREAT improves functional interpretation of cis-regulatory regions , 2010, Nature Biotechnology.

[34]  C. Wijmenga,et al.  Genome-wide association analysis in primary sclerosing cholangitis. , 2010, Gastroenterology.

[35]  S. Curbishley,et al.  Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells. , 2009, Gastroenterology.

[36]  Qiang Tian,et al.  Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes , 2006, Cell Research.

[37]  I. N. Crispe,et al.  Complete differentiation of CD8+ T cells activated locally within the transplanted liver , 2006, The Journal of experimental medicine.

[38]  A. McMichael,et al.  Human Naive CD8 T Cells Down-Regulate Expression of the WNT Pathway Transcription Factors Lymphoid Enhancer Binding Factor 1 and Transcription Factor 7 (T Cell Factor-1) following Antigen Encounter In Vitro and In Vivo1 , 2006, The Journal of Immunology.

[39]  S. Curbishley,et al.  Hepatic Endothelial CCL25 Mediates the Recruitment of CCR9+ Gut-homing Lymphocytes to the Liver in Primary Sclerosing Cholangitis , 2004, The Journal of experimental medicine.

[40]  Youjin Lee,et al.  Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues. , 2003, The Journal of clinical investigation.

[41]  Y. Shiratori,et al.  Stromal Cell–Derived Factor-1 from Biliary Epithelial Cells Recruits CXCR4-Positive Cells: Implications for Inflammatory Liver Diseases , 2003, Laboratory Investigation.

[42]  G. Reynolds,et al.  Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. , 2002, The American journal of pathology.

[43]  D. Adams,et al.  MAdCAM‐1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM‐1 in chronic inflammatory liver disease) , 2001, Hepatology.

[44]  E. Dickson,et al.  Primary Sclerosing Cholangitis , 1984, The New England journal of medicine.

[45]  D. Bogdanos,et al.  Liver immunology. , 2013, Comprehensive Physiology.

[46]  Christian Gieger,et al.  Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci , 2011, Nature Genetics.

[47]  J. Herkel,et al.  Immune-mediated liver injury. , 2005, Journal of hepatology.

[48]  F. Azzaroli,et al.  Immunology of the healthy liver: old questions and new insights. , 2001, Gastroenterology.